Netmeds vs 1mg vs PharmEasy
The online pharmacy market in India has grown rapidly, especially with the rise in digital health trends. Platforms like Netmeds, 1mg, and PharmEasy have become household names, helping people buy medicines online easily.
This blog explores the comparison of these three major players across various aspects such as business models, market presence, technology, user experience, valuation, and investors. To support such growing demand and enhance customer experience, pharmacy delivery app development has become essential. These services offer fast, secure, and user-friendly solutions that enable pharmacies to expand their digital presence and streamline medicine delivery operations.
Business Models
Netmeds
Netmeds operates on a marketplace model, offering prescription and OTC medicines through partnered pharmacies. Their platform connects users with local stores for fast tablet delivery, similar to other online pharmacy apps. Netmeds also promotes lab tests and teleconsultations, enhancing its digital healthcare ecosystem.
1 mg
1mg, recently rebranded under Tata 1mg, follows a hybrid model. It provides medicines directly and via third-party pharmacies. It also focuses heavily on lab tests, health content, and doctor consultations, setting it apart from typical medicine mart platforms. This holistic approach strengthens its position as the best online medicine delivery app in India.
PharmEasy
PharmEasy began as a logistics player for local chemists but evolved into a full-stack pharmacy app. It now offers a wide range of services, including medicine delivery, lab tests, and doctor consultations. Its strong backend tech and large network make it a serious contender for the best online medicine delivery brand.
Market Presence and Reach
Netmeds
Owned by Reliance Retail, Netmeds.com has nationwide coverage. It caters to metro and tier-2 cities through its wide pharmacy network. With Reliance's retail strength, the platform benefits from offline-to-online (O2O) capabilities.
1 mg
1mg has strong brand visibility, especially in urban India. The Tata acquisition expanded its footprint and credibility. It has a significant edge in the diagnostics sector, adding more touch points beyond just being a pharmacy app.
PharmEasy
PharmEasy boasts deep reach, especially after its merger with Metlife and acquisition of Thyrocare. It serves both urban and semi-urban areas, with high delivery coverage. Among online pharmacy apps, PharmEasy leads in volume and variety.
Technological Innovation
Netmeds
Netmeds features a user-friendly online medicine shopping app that includes e-prescription uploads, smart refill reminders, and AI-based recommendations. These features aim to make ordering tablets online easier and more personalized.
1 mg
1mg invests heavily in digital health records, AI-powered health content, and predictive diagnostics. It uses ML to match users with suitable products and services, giving it a tech-forward reputation among online medicine app users.
PharmEasy
PharmEasy leverages technology for real-time order tracking, inventory automation, and prescription parsing. Its platform supports lab integration and partner pharmacy onboarding, key traits for a medicine delivery app in 2025.
Customer Experience and App Usability
User Interface
All three apps provide clean, responsive designs. However, 1mg stands out with better visual hierarchy and smoother navigation, making it user-friendly even for first-time users.
Order Process
PharmEasy leads in speed and simplicity. Its intuitive steps from searching for medicine to uploading a prescription and checking out reflect the qualities of the best online medicine app experience.
Delivery & Support
Netmeds ensures fast delivery in most metros, while PharmEasy offers consistent updates and real-time tracking. 1mg, with Tata's backing, provides professional customer support, especially for health packages and diagnostics.
Valuation
Netmeds
Reliance acquired a majority stake in Netmeds for around $83 million, reflecting its strategic importance in the pharmacy online app space.
1 mg
1mg is now a Tata Digital subsidiary, and recent funding rounds suggest a valuation near $450–500 million. Its diagnostic segment boosts its long-term market value.
PharmEasy
PharmEasy has been valued at over $5 billion, especially after acquiring Thyrocare. It is India’s first e-pharmacy unicorn and is often seen as the leader in medicine delivery app development.
Investors
Netmeds Investors
Initially backed by OrbiMed and Daun Penh Cambodia Group, Netmeds drew Reliance’s attention, leading to a full acquisition.
Tata 1mg Investors
1mg was funded by Sequoia Capital and others before Tata Digital acquired a majority stake. Tata’s entry gave it a major credibility boost in the pharmacy app development company space.
PharmEasy Investors
PharmEasy has attracted big names like Temasek, Prosus, and TPG. Its aggressive growth model and acquisitions make it a favorite for those investing in online pharmacy app development.
Conclusion
Platforms like Netmeds, 1mg, and PharmEasy offer valuable insights to choose a buy-medicines-online app for personal use or explore ideas for the best medicine app in India. Each has its own strengths. Netmeds with Reliance's scale, 1mg with Tata's trust, and PharmEasy with aggressive tech and market moves.
If you're a startup aiming to enter the space, now is the time to connect with a Medicine Delivery App Development Company. Building a successful Pharmacy App today means understanding what these giants did right and how to innovate beyond them.
Need a Custom Pharmacy App? Connect with a top-rated Pharmacy App Development Company that specializes in scalable, secure, and user-friendly platforms tailored for the healthcare and medicine delivery industry.
